IITs represent an important pathway for exploring new drug indications and therapeutic strategies and serve as a key driver of medical innovation. Over the next three years, the Alliance plans to advance 10–20 innovative therapeutic candidates to the proof-of-concept stage in clinical development. Through this platform, Nona Biosciences will gain earlier and deeper insights into unmet clinical needs and access to leading scientific research capabilities, ultimately accelerating the development of innovative ...